Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved a new, simplified monthly dosing schedule* for RYBREVANT FASPROtm (amivantamab and hyaluronidase-lpuj). When ...
Unlike platforms that treat AI as a standalone feature, Ecer has embedded intelligence into the entire trade lifecycle. From product information management and global promotion to customer ...
SHANGHAI, SHANGHAI, CHINA, January 27, 2026 /EINPresswire.com/ -- As a Global Leading Hyperbaric Oxygen Chamber ...
Abstract: The paper introduces an agent-based Proactive Fault Tolerance and Management (PFTM) architecture for small satellite missions, designed to improve reliability and autonomy. The architecture ...
ToolKitX’s privacy-first HSE Software reflects a broader shift toward intelligent, data-driven safety management across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results